Main menu

Hematopathologist

Foundation Medicine is dedicated to helping bring personalized cancer medicine into routine clinical practice. Harnessing advanced technology, Foundation Medicine has developed clinical laboratory tests that broadly captures the most relevant tumor genomic and other molecular information and connects it with relevant scientific and medical knowledge to help oncologists determine the right treatment for each patient. This is a diverse, fast-paced, team oriented environment integrating laboratory science, cancer genetics and genomics, process data metrics and clinical data.

Responsibilities:

Co-Develop and oversee the fluorescence in situ hybridization service with Christine Sheehan (consultant) for break apart analysis of ALK and ROS1 fusions in NSCLC

Establish and oversee the allele-specific PCR assays for hotspot detection of EGFR, BRAF, KRAS and other mutations in FFPE samples

Participate in pathology review of incoming samples for all on site FMI testing including FoundationOne

Provide professional interpretation IHC service for PD-1/PD-L1 testing and other IHC assays that are developed

Provide professional interpretation FISH service for ALK/ROS1 and other break apart assays

Play a major role in all Quality Assurance and test validation programs for the NC lab

Provide support for the FMI Commercial team including travel to provide programs at hospitals, cancer centers and medical/scientific meetings

Perform research studies leading to abstracts and full-length papers supporting and promoting FMI tests and services in the peer-reviewed scientific literature

Requirements

Formal Training in Anatomic and Molecular Pathology

Board Certification in Anatomic Pathology and Molecular Pathology

Medical Licensure in North Carolina

Eligibility for Certificate of Qualification in Cellular and Molecular Oncology from the NYSDOH